Effect of single nucleotide polymorphism in thrombin-activatable fibrinolysis inhibitor on the risk of diabetic macrovascular disease.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Mar 26 (2): 185-90.
Zheng Chenghong, Li Xiaochao, Kong Caixia, Ke Shuhong, Peng Cong, Cui Tianpen, Gao Mingsong, Zhou Yang, Guo Wei, Huang Lianqi, Petersen Robert B, Huang K
- Page last reviewed:Mar 1, 2018
- Page last updated:Jun 13, 2019
- Content source: